Global Oncology Biosimilars Market Study 2016-2026, by Segment (G-CSF, Hematopoietic Agents, … …), by Market (Retail Pharmacies, Hospital Pharmacies, … …), by Company (Celltrion Inc., Pfizer Inc., … …)
SKU ID :99ST-14637160 | Published Date: 23-Oct-2019 | No. of pages: 47Description
Summary
The global Oncology Biosimilars market will reach Volume Million USD in 2019 and with a CAGR xx% between 2020-2026.
G-CSF
Hematopoietic Agents
Monoclonal Antibodies
Demand Coverage (Market Size & Forecast, Consumer Distribution):
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies
Celltrion Inc.
Pfizer Inc.
Biocon
BIOCAD
Apotex Inc.
Dr. Reddy's
Sandoz International GmbH
Intas Pharmaceuticals Ltd.
STADA Arzneimittel AG
Teva Pharmaceutical Industries Ltd
North America
Europe
Asia-Pacific
South America
Middle East & Africa
The global Oncology Biosimilars market will reach Volume Million USD in 2019 and with a CAGR xx% between 2020-2026.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
G-CSF
Hematopoietic Agents
Monoclonal Antibodies
Demand Coverage (Market Size & Forecast, Consumer Distribution):
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies
Company Coverage (Sales data, Main Products & Services etc.):
Celltrion Inc.
Pfizer Inc.
Biocon
BIOCAD
Apotex Inc.
Dr. Reddy's
Sandoz International GmbH
Intas Pharmaceuticals Ltd.
STADA Arzneimittel AG
Teva Pharmaceutical Industries Ltd
Major Region
MarketNorth America
Europe
Asia-Pacific
South America
Middle East & Africa
TOC
Tables & Figures
Companies
- PRICE
-
$1800$3600Buy Now